MAY 07, 2019 2:53 PM PDT

Siblings lead Researchers to Discover New Immunodeficiency Disease

WRITTEN BY: Tiffany Dazet

An infant was suffering from inflammatory bowel disease, eczema, food allergies, lung disease, and persistent cytomegalovirus (CMV) infection. His older sister was experiencing similar problems. The scientific investigation of their cases led researchers from the University of Colorado Anschutz Medical Campus to discover a new immunodeficiency disease that is caused by a single genetic mutation. Their findings were published last week in The Journal of Experimental Medicine.

The siblings’ symptoms were consistent with an immune dysregulation syndrome, which can lead to an increased cancer risk. Upon closer examination, researchers discovered a defect in a gene called IL2RB (encoding interleukin-2 receptor beta, IL-2R?), which causes a decrease in the number of immune cells (regulatory T cells) that prevent autoimmunity. These two children are the first known humans to have this genetic defect. 

Image via JEM

In addition to a decreased number of regulatory T cells, the siblings also had an accumulation of “natural killer” cells. When functioning correctly, natural killer cells protect against viral infections and cancer. However, in a press release from the University of Colorado medical campus, co-author Elena Hsieh, MD explains that “the mutation meant that the natural killer cells were incapable of maturing properly and could not clear CMV, resulting in persistent and debilitating infection.”

Hsieh emphasizes the rarity of tracking down a disease to a single gene; especially since there were not any documented cases of mutations in this gene that can lead to human disease. Co-author Cullen Dutmer, MD believes that others may likely suffer from this condition, but it hasn’t been identified. In the press release he states that “although clearly a rare disease, it has likely been missed in other children. Now that it is out there, we know to look for it.”

Researchers are hopeful that this genetic defect can be treated with gene therapy. Co-author Ross Kedl, Ph.D., suggests that “we could feasibly go in, manipulate the gene, and get it back in the right sequence.” Gene therapy is becoming a more viable treatment option with recent advances in identifying genetic causes of immunodeficiency diseases. Dutmer and Hsieh are hopeful that once a genetic cause is identified “that would allow for therapeutic interventions that are uniquely tailored to meet the need of the individuals.”

Sources: Journal of Experimental Medicine, CU Anschutz Today, Science Daily
 

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
JUL 08, 2020
Drug Discovery & Development
Common Blood Pressure Drugs May Prevent Colon Cancer
JUL 08, 2020
Common Blood Pressure Drugs May Prevent Colon Cancer
Colon cancer is the third most common cancer and the second leading cause of death by cancer around the world. Now, rese ...
JUL 08, 2020
Health & Medicine
The Myths About CBD and Coronavirus
JUL 08, 2020
The Myths About CBD and Coronavirus
Research collected over the last 20 years suggests that cannabidiol – the primary cannabinoid in CBD oil – h ...
JUL 07, 2020
Cannabis Sciences
Marijuana Users are Better at Sticking to a Fitness Program
JUL 07, 2020
Marijuana Users are Better at Sticking to a Fitness Program
Forget the go-to stereotype of a lazy stoner. In fact, older people who consume marijuana are more, not less, likely to ...
JUL 10, 2020
Cancer
Researching New RNA Biomarkers for Liver Cancer
JUL 10, 2020
Researching New RNA Biomarkers for Liver Cancer
The most important part of cancer treatment is the first step, diagnosis. Many cancers can lie dormant for years, reachi ...
JUL 17, 2020
Immunology
More Potential Antibody Therapies for COVID Emerge
JUL 17, 2020
More Potential Antibody Therapies for COVID Emerge
When it comes to clinical countermeasures against COVID-19, one class of molecules stands out among the others: antibodi ...
JUL 23, 2020
Cardiology
Protecting the Heart After a Heart Attack
JUL 23, 2020
Protecting the Heart After a Heart Attack
Cardiovascular disease accounts for thirty percent of mortalities around the world. These diseases start small and slowl ...
Loading Comments...